Q2 2024 EPS Estimates for Encompass Health Co. (NYSE:EHC) Reduced by William Blair

Encompass Health Co. (NYSE:EHC) – Equities researchers at William Blair decreased their Q2 2024 earnings per share estimates for Encompass Health in a note issued to investors on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will post earnings per share of $0.96 for the quarter, down from their prior forecast of $0.97. William Blair has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $3.96 per share. William Blair also issued estimates for Encompass Health’s Q3 2024 earnings at $0.94 EPS, Q4 2024 earnings at $0.99 EPS, FY2024 earnings at $4.01 EPS, Q3 2025 earnings at $1.07 EPS, Q4 2025 earnings at $1.13 EPS and FY2025 earnings at $4.58 EPS.

Several other research firms also recently commented on EHC. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Truist Financial lifted their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Stephens reiterated an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. Raymond James restated a “strong-buy” rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a report on Friday. Finally, Barclays boosted their price target on Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $86.56.

Encompass Health Trading Down 0.3 %

NYSE EHC opened at $82.46 on Friday. The stock’s 50-day simple moving average is $78.25 and its two-hundred day simple moving average is $70.87. Encompass Health has a twelve month low of $57.55 and a twelve month high of $85.84. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $8.26 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.53 and a beta of 0.94.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a return on equity of 18.48% and a net margin of 7.60%. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the business posted $0.88 earnings per share. The company’s revenue for the quarter was up 13.4% on a year-over-year basis.

Institutional Trading of Encompass Health

Hedge funds have recently made changes to their positions in the stock. Principal Securities Inc. bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $25,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of Encompass Health by 360.2% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after purchasing an additional 317 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $30,000. GAMMA Investing LLC bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $33,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in shares of Encompass Health in the 3rd quarter worth approximately $35,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were given a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.73%. Encompass Health’s payout ratio is 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.